Although these agents offer transformative therapeutic potential, their optimal use requires individualized care, careful patient selection, and ongoing safety surveillance
These medicines work on two different areas of the brain and work especially well for people with strong cravings for food
PSM Executive Director Shabbir Imber Safdar released the following statement in response to news that Hims & Hers is now compounding pill versions of a newly approved GLP-1 weight-loss drug
The OPTION-DM trial was a multicenter, randomized, crossover study comparing three monotherapy sequences (amitriptyline, duloxetine, pregabalin) against two dual-therapy sequences in patients who had failed one monotherapy [65]
In the cluster analyses, we chose input covariates using a prevalence threshold of 1%, leading to 65 and 84 input covariates for diagnoses and medications data, respectively
If your medical provider determines you are not eligible for an EllieMD program, your payment will be refunded